MDMA: Interactions with other psychoactive drugs

Pharmacology Biochemistry and Behavior

Volumn 99, Issue 4, 2011, Pages 759-774

  Mohamed, Wael M Y ^a   Hamida, Sami Ben ^b,c   Cassel, Jean Christophe ^b   De Vasconcelos, Anne Pereira ^b   Jones, Byron C ^a  

^a PENNSYLVANIA STATE UNIVERSITY   (United States)

^b UNIVERSITÉ DE STRASBOURG   (France)

^c UNIVERSITY OF CALIFORNIA SAN FRANCISCO   (United States)

Author keywords

9 THC; 3,4 Methylenedioxymethamphetamine (MDMA); Caffeine; Cocaine; Ecstasy; Ethanol; Hyperthermia; Interaction

Indexed keywords

3,4 METHYLENEDIOXYMETHAMPHETAMINE; 4 HYDROXYBUTYRIC ACID; 4 METHOXYAMPHETAMINE; ALCOHOL; ALDOSTERONE; AMPHETAMINE DERIVATIVE; ANTIDEPRESSANT AGENT; CAFFEINE; CANNABIS; CITALOPRAM; CLOZAPINE; COCAINE; DIAMORPHINE; EPHEDRINE; FLUNITRAZEPAM; FLUOXETINE; KETAMINE; KETANSERIN; LYSERGIDE; METHAMPHETAMINE; MORPHINE; NALTREXONE; NICOTINE; OLANZAPINE; OPIATE; OXYTOCIN; PROLACTIN; PSYCHEDELIC AGENT; PSYCHOTROPIC AGENT; SEROTONIN UPTAKE INHIBITOR;

ACUTE KIDNEY FAILURE; AGGRESSION; ALDOSTERONE BLOOD LEVEL; ALPHA RHYTHM; ANHEDONIA; ANXIETY; APOPTOSIS; ATTENTION; AUSTRALIA; BLOOD PLACENTA BARRIER; BRAIN HEMORRHAGE; CARDIOVASCULAR FUNCTION; CAUSE OF DEATH; CIGARETTE SMOKING; CLUBFOOT; COGNITIVE DEFECT; COMMON COLD; CONGENITAL HEART MALFORMATION; CONVULSION; DECISION MAKING; DEPRESSION; DEPTH PERCEPTION; DISEASE PREDISPOSITION; DISSEMINATED INTRAVASCULAR CLOTTING; DOPAMINE RELEASE; DOPAMINERGIC ACTIVITY; DRIVING ABILITY; DROWSINESS; DRUG ABUSE; DRUG ALCOHOL INTERACTION; DRUG ANTAGONISM; DRUG EFFECT; DRUG FATALITY; DRUG METABOLISM; DRUG POTENTIATION; DRUG PURITY; DRUG SEEKING BEHAVIOR; DRUG SENSITIZATION; DRUG USE; DYSPHORIA; ELECTROENCEPHALOGRAM; EMPATHY; ENDOCRINE DISEASE; ENERGY; ENVIRONMENTAL TEMPERATURE; EUPHORIA; EXECUTIVE FUNCTION; EXPERIMENTAL MOUSE; EXPERIMENTAL PIG; EXPERIMENTAL RABBIT; EXPERIMENTAL RAT; FATIGUE; FLUENCY DISORDER; FLUID RETENTION; GROUPS BY AGE; HALLUCINATION; HEALTH HAZARD; HEART RATE; HUMAN; HYPERTENSION; HYPERTHERMIA; HYPONATREMIA; HYPOTHERMIA; IMMUNITY; IMPULSE CONTROL DISORDER; IMPULSIVENESS; IRRITABILITY; LEARNING DISORDER; LIVER TOXICITY; LOCOMOTION; MEMORY; MENTAL DISEASE; MONOAMINE METABOLISM; MOOD; MOTOR DEVELOPMENT; MULTIPLE DRUG ABUSE; NERVOUS SYSTEM DEVELOPMENT; NEUROCHEMISTRY; NEUROSIS; NEUROTOXICITY; NEUROTRANSMISSION; NONHUMAN; NORADRENALIN RELEASE; NORTH AMERICA; NUCLEUS ACCUMBENS; OBSESSIVE COMPULSIVE DISORDER; OXIDATIVE STRESS; OXYTOCIN BLOOD LEVEL; PARANOIA; PERINATAL DRUG EXPOSURE; PHARYNGITIS; PHYSICAL DEVELOPMENT; PHYSICAL DISEASE; PLACE PREFERENCE; PREGNANT WOMAN; PRIMATE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PSYCHOMOTOR ACTIVITY; PSYCHOSIS; REINFORCEMENT; RESTLESSNESS; REVIEW; REWARD; RHABDOMYOLYSIS; SEIZURE; SEROTONIN RELEASE; SEROTONIN SYNDROME; SINUSITIS; SOCIAL CLASS; SOCIAL INTERACTION; SOMATOFORM DISORDER; SYNAPSE; TACHYCARDIA; TERATOGENICITY; THERMOREGULATION; THETA RHYTHM; UNITED KINGDOM; UNITED STATES; URINARY TRACT INFECTION; VASODILATATION; VASOPRESSIN RELEASE; VISION; VISUOMOTOR COORDINATION; WESTERN EUROPE; WITHDRAWAL SYNDROME;

AMPHETAMINE; AMPHETAMINE-RELATED DISORDERS; ANIMALS; CAFFEINE; CANNABIS; CENTRAL NERVOUS SYSTEM DEPRESSANTS; COCAINE; DRUG INTERACTIONS; ETHANOL; HALLUCINOGENS; HUMANS; N-METHYL-3,4-METHYLENEDIOXYAMPHETAMINE; NICOTINE; PSYCHOTROPIC DRUGS; SUBSTANCE-RELATED DISORDERS;

CANNABIS SATIVA; NICOTIANA TABACUM; RODENTIA;

EID: 80051782945     PISSN: 00913057     EISSN: 18735177     Source Type: Journal    
DOI: 10.1016/j.pbb.2011.06.032     Document Type: Review

References (337)

1. M. Aberg, D. Wade, E. Wall, and S. Izenwasser Effect of MDMA (ecstasy) on activity and cocaine conditioned place preference in adult and adolescent rats Neurotoxicol Teratol 29 2007 37 46 (Pubitemid 46205157)
2. C. Achat-Mendes, K.L. Anderson, and Y. Itzhak Methylphenidate and MDMA adolescent exposure in mice: long lasting consequences on cocaine induced reward and psychomotor stimulation in adulthood Neuropharmacology 45 2003 106 115 (Pubitemid 36695015)
3. D.H. Adams, G.R. Hanson, and K.A. Keefe 3,4-Methylenedioxymethamphetamine increases neuropeptide messenger RNA expression in rat striatum Mol Brain Res 133 2005 131 142 (Pubitemid 40127498)
4. A. Agrawal, M.C. Neale, C.A. Prescott, and K.S. Kendler A twin study of early cannabis use and subsequent use and abuse dependence of other illicit drugs Psychol Med 34 2004 1227 1237 (Pubitemid 39517153)
5. T.A. Alvarenga, M.L. Andersen, D.A. Ribeiro, P. Araujo, C. Hirotsu, J.L. Costa, M.C. Battisti, and S. Tufik Single exposure to cocaine or ecstasy induces DNA damage in brain and other organs of mice Addict Biol 15 2010 96 99
6. R.D. Ando, C. Adori, E. Kirilly, E. Molnar, G.G. Kovacs, L. Ferrington, P.A. Kelly, and G. Bagdy Acute SSRI-induced anxiogenic and brain metabolic effects are attenuated 6 months after initial MDMA-induced depletion Behav Brain Res 207 2010 280 289
7. M.G. Bankson, and B.K. Yamamoto Serotonin-GABA interactions modulate MDMA-induced mesolimbic dopamine release J Neurochem 91 2004 852 859 (Pubitemid 39507362)
8. M. Barenys, N. Macia, L. Camps, J. de Lapuente, J. Gomez-Catalan, J. Gonzalez-Linares, M. Borras, M. Rodamilans, and J.M. Llobet Chronic exposure to MDMA (ecstasy) increases DNA damage in sperm and alters testes histopathology in male rats Toxicol Lett 191 2009 40 46
9. S.P. Barrett, S.R. Gross, I. Garand, and R.O. Pihl Patterns of simultaneous polysubstance use in Canadian rave attendees Subst Use Misuse 40 2005 1525 1537 (Pubitemid 41098807)
10. S.P. Barrett, C. Darredeau, and R.O. Pihl Patterns of simultaneous polysubstance use in drug using university students Hum Psychopharmacol 21 2006 255 263 (Pubitemid 44043769)
11. G. Battaglia, S. Yeh, and E.B. De Souza MDMA-induced neurotoxicity: parameters of degeneration and recovery of brain serotonin neurons Pharmacol Biochem Behav 29 1988 269 274 (Pubitemid 19258259)
12. M.H. Baumann, X. Wang, and R.B. Rothman 3,4-Methylenedioxymethamphetamine (MDMA) neurotoxicity in rats: a reappraisal of past and present findings Psychopharmacology (Berlin). 189 2007 407 424 (Pubitemid 44791212)
13. G. Beitia, A. Cobreros, L. Sainz, and E. Cenarruzabeitia Ecstasy-induced toxicity in rat liver Liver 20 2000 8 15 (Pubitemid 30095283)
14. S.B. Ben Hamida, S. Bach, E. Plute, B.C. Jones, C. Kelche, and J.C. Cassel Ethanol-ecstasy (MDMA) interactions in rats: preserved attenuation of hyperthermia and potentiation of hyperactivity by ethanol despite prior ethanol treatment Pharmacol Biochem Behav 84 2006 162 168 (Pubitemid 43996915)
15. S. Ben Hamida, E. Plute, S. Bach, C. Lazarus, P. Tracqui, C. Kelche, A.P. de Vasconcelos, B.C. Jones, and J.C. Cassel Ethanol-MDMA interactions in rats: the importance of interval between repeated treatments in biobehavioral tolerance and sensitization to the combination Psychopharmacology (Berlin). 192 2007 555 569 (Pubitemid 46870750)
16. S.B. Ben Hamida, E. Plute, B. Cosquer, C. Kelche, B.C. Jones, and J.C. Cassel Interactions between ethanol and cocaine, amphetamine, or MDMA in the rat: thermoregulatory and locomotor effects Psychopharmacology (Berl). 197 2008 67 82 (Pubitemid 351406285)
17. R. Ben-Abraham, O. Szold, V. Rudick, and A.A. Weinbroum Ecstasy intoxication: life-threatening manifestations and resuscitative measures in the intensive care setting Eur J Emerg Med 10 2003 309 313
18. U.V. Berger, X.F. Gu, and E.C. Azmitia The substituted amphetamines 3,4-methylenedioxymethamphetamine, methamphetamine, p-chloroamphetamine and fenfluramine induce 5-hydroxytryptamine release via a common mechanism blocked by fluoxetine and cocaine Eur J Pharmacol 215 1992 153 160
19. S.P. Bessman, and W.N. Fishbein Gamma-hydroxybutyrate, a normal brain metabolite Nature 200 1963 1207 1208
20. E.J. Bilsky, C.L. Hubbell, J.D. Delconte, and L.D. Reid MDMA produces a conditioned place preference and elicits ejaculation in male rats: a modulatory role for the endogenous opioids Pharmacol Biochem Behav 40 1991 443 447
21. E.J. Bilsky, M.J. Montegut, M.L. Nichols, and L.D. Reid CGS 10746B, a novel dopamine release inhibitor, blocks the establishment of cocaine and MDMA conditioned place preferences Pharmacol Biochem Behav 59 1998 215 220 (Pubitemid 28053701)
22. W.W. Blessing, B. Seaman, N.P. Pedersen, and Y. Ootsuka Clozapine reverses hyperthermia and sympathetically mediated cutaneous vasoconstriction induced by 3,4-methylenedioxymethamphetamine (ecstasy) in rabbits and rats J Neurosci 23 2003 6385 6391 (Pubitemid 36875641)
23. W.W. Blessing, A. Zilm, and Y. Ootsuka Clozapine reverses increased brown adipose tissue thermogenesis induced by MDMA and by cold exposure in conscious rats Neuroscience 141 2006 2067 2073 (Pubitemid 44251170)
24. A.R. Bodenham, and A. Mallick New dimensions in toxicology: hyperthermic syndrome following amphetamine derivatives Intensive Care Med 22 1996 622 664
25. C.W. Bradberry Dynamics of extracellular dopamine in the acute and chronic actions of cocaine Neuroscientist 8 2002 315 322 (Pubitemid 34824015)
26. D. Braida, and M. Sala Role of the endocannabinoid system in MDMA intracerebral self-administration in rats Br J Pharmacol 136 2002 1089 1092 (Pubitemid 34970059)
27. D. Braida, S. Iosue, S. Pegorini, and M. Sala 3,4 Methylenedioxymethamphetamine-induced conditioned place preference (CPP) is mediated by endocannabinoid system Pharmacol Res 51 2005 177 182 (Pubitemid 40040550)
28. M.L. Brecht, and C. von Mayrhauser Differences between Ecstasy using and nonusing methamphetamine users J Psychoactive Drugs 34 2002 215 223 (Pubitemid 34809991)
29. C. Breen, L. Degenhardt, S. Kinner, R. Bruno, R. Jenkinson, A. Mattews, and J. Newman Alcohol use and risk taking among regular ecstasy users Subst Use Misuse 41 2006 1095 1109 (Pubitemid 43977358)
30. K.A. Brennan, C. Carati, R.A. Lea, P.S. Fitzmaurice, and S. Schenk Effects of D1-like and D2-like receptor antagonists on methamphetamine and MDMA self-administration in rats Behav Pharmacol 20 2009 688 694
31. J. Brodkin, A. Malyala, and J.F. Nash Effect of acute monoamine depletion on MDMA-induced neurotoxicity Pharmacol Biochem Behav 45 1993 647 653
32. P.L. Brown, and E.A. Kiyatkin Brain hyperthermia induced by MDMA (ecstasy): modulation by environmental conditions Eur J Neurosci 20 2004 51 58 (Pubitemid 38932126)
33. J.J. Burmeister, E.M. Lungren, K.F. Kirschner, and J.L. Neisewander Differential roles of 5-HT receptor subtypes in cue and cocaine reinstatement of cocaine-seeking behavior in rats Neuropsychopharmacology 29 2004 660 668 (Pubitemid 38402473)
34. N. Burns, H.J. Olverman, P.A. Kelly, and B.C. Williams Effects of ecstasy on aldosterone secretion in the rat in vivo and in vitro Endocr Res 22 1996 601 606 (Pubitemid 26424384)
35. R.W. Byard, N.G. Rodgers, R.A. James, C. Kostakis, and A.M. Camilleri Death and paramethoxyamphetamine....an evolving problem Med J Aust 176 2002 496
36. C. Cadoni, M. Solinas, A. Pisanu, G. Zernig, E. Acquas, and G. Di Chiara Effect of 3,4 methylendioxymethamphetamine (MDMA, "ecstasy") on dopamine transmission in the nucleus accumbens shell and core Brain Res 1055 2005 143 148 (Pubitemid 41224238)
37. P.D. Callaghan, R.J. Irvine, and L.C. Daws Differences in the in vivo dynamics of neurotransmitter release and serotonin uptake after acute paramethoxyamphetamine and 3,4-methylenedioxymethamphetamine revealed by chronoamperometry Neurochem Int 47 2005 350 361 (Pubitemid 40968019)
38. C.W. Callaway, and M.A. Geyer Tolerance and cross-tolerance to the activating effects of 3,4-methylenedioxymethamphetamine and a 5-hydroxytryptamine1B agonist J Pharmacol Exp Ther 263 1992 318 326
39. J. Camarasa, D. Pubill, and E. Escubedo Association of caffeine to MDMA does not increase antinociception but potentiates adverse effects of this recreational drug Brain Res 1111 2006 72 82 (Pubitemid 44331182)
40. J. Cami, M. Farre, M.L. Gonzalez, J. Segura, and T.R. de la Cocaine metabolism in humans after use of alcohol. Clinical and research implications Recent Development in Alcoholism. 14 1998 437 455
41. N.G. Campbell, J.B. Koprich, N.M. Kanaan, and J.W. Lipton MDMA administration to pregnant Sprague-Dawley rats results in its passage to the fetal compartment Neurotoxicol. Teratol. 28 2006 459 465 (Pubitemid 44332878)
42. M.E. Carroll, S.T. Lac, M. Asencio, and R. Kragh Fluoxetine reduces intravenous cocaine self-administration in rats Pharmacol Biochem Behav 35 1990 237 244 (Pubitemid 20034592)
43. M. Carvalho, N. Milhazes, F. Remião, F. Borges, E. Fernandes, F. Amado, T.J. Monks, F. Carvlho, and M.L. Bastos Hepatotoxicity of 3,4-methlenedioxyamphetamine and alpha-methyldopamine in isolated rat hepatocytes: formation of glutathione conjugates Arch Toxicol 78 2004 16 24 (Pubitemid 38269935)
44. J.C. Cassel, H. Jeltsch, J. Koenig, and B.C. Jones Locomotor and pyretic effects of MDMA-ethanol association in rats Alcohol 34 2004 285 289 (Pubitemid 40292788)
45. J.C. Cassel, C. Riegert, S. Rutz, J. Koenig, K. Rothmaier, B. Cosquer, C. Lazarus, A. Birthelmer, H. Jeltsch, B.C. Jones, and R. Jackisch Ethanol, 3,4-methylenedioxymethamphetamine (ecstasy) and their combination: long-term behavioral, neurochemical and neuropharmacological effects in the rat Neuropsychopharmacology 30 2005 1870 1882 (Pubitemid 41486412)
46. J.C. Cassel, S. Ben Hamida, and B.C. Jones Attenuation of MDMA-induced hyperthermia by ethanol in rats depends on ambient temperature Eur J Pharmacol 571 2007 152 155 (Pubitemid 47385899)
47. Cassel JC, Ben Hamida S, Jones BC. Ethanol and MDMA: a comment on the paper by Dumont et al. Psychopharmacol. 2008;200:305-6
48. K.J. Clemens, P.S. Van Nieuwenhuyzen, K.M. Li, J.L. Cornish, G.E. Hunt, and I.S. McGregor MDMA ("ecstasy"), methamphetamine and their combination: long-term changes in social interaction and neurochemistry in the rat Psychopharmacology (Berlin). 173 2004 318 325 (Pubitemid 38703805)
49. K.J. Clemens, J.L. Cornish, K.M. Li, G.E. Hunt, and I.S. McGregor MDMA ('ecstasy') and methamphetamine combined: order of administration influences hyperthermic and long-term adverse effects in female rats Neuropharmacology 49 2005 195 207 (Pubitemid 40933758)
50. K.J. Clemens, J.L. Cornish, G.E. Hunt, and I.S. McGregor Intravenous methamphetamine self-administration in rats: effects of intravenous or intraperitoneal MDMA co-administration Pharmacol Biochem Behav 85 2006 454 463 (Pubitemid 44881088)
51. K.J. Clemens, I.S. McGregor, G.E. Hunt, and J.L. Cornish MDMA, methamphetamine and their combination: possible lessons for party drug users from recent preclinical research Drug Alcohol Rev 26 2007 9 15
52. J.C. Cole, and H.R. Sumnall Altered states: the clinical effects of ecstasy Pharmacol Ther 98 2003 35 58 (Pubitemid 36355889)
53. J.C. Cole, M. Bailey, H.R. Sumnall, G.F. Wagstaff, and L.A. King The content of ecstasy tablets: implications for the study of their long-term effects Addiction 97 2002 1531 1536 (Pubitemid 36009109)
54. J.C. Cole, H.R. Sumnall, E. O'Shea, and C.A. Marsden Effects of MDMA exposure on the conditioned place preference produced by other drugs of abuse Psychopharmacology (Berl). 166 2003 383 390 (Pubitemid 36469940)
55. J. Colussi-Mas, R.J. Wise, A. Howard, and S. Schenk Drug seeking in response to a priming injection of MDMA in rats: relationship to initial sensitivity to self-administered MDMA and dorsal striatal dopamine Int J Neuropsychopharmacol 13 2010 1315 1327
56. V. Compan, K. Scearce-Levie, C. Crosson, A. Daszuta, and R. Hen Enkephalin contribute to the locomotor stimulating effects of 3,4-methylendioxy-N-methyamphetamine Eur J Neurosci 18 2003 383 390 Eur J Neurosci. 2003;18:383-90 (Pubitemid 37006431)
57. T.J. Connor MDMA: a stressor on the immune system Immunology 111 2004 357 367
58. T.J. Connor, M.G. McNamara, D. Finn, A. Currid, M. O'Malley, A.M. Redmond, J.P. Kelly, and B.E. Leonard Acute 3,4-methoxylenedioxymethamphetamine (MDMA) administration produced a rapid and sustained suppression of immune function in the rat Immunopharmacology 38 1998 253 260 (Pubitemid 28064595)
59. J. Copeland, P. Dillon, and M. Gascoigne Ecstasy and the concomitant use of pharmaceuticals Addict Behav 31 2006 367 370 (Pubitemid 43144895)
60. J.L. Cornish, Z. Shahnawaz, M.R. Thompson, S. Wong, K.C. Morley, G.E. Hunt, and I.S. McGregor Heat increases 3,4-methylenedioxymethamphetamine self-administration and social effects in rats Eur J Pharmacol 482 2003 339 341 (Pubitemid 37505963)
61. R.L. Cowan, D.M. Roberts, and J.M. Joers Neuroimaging in human MDMA (Ecstasy) users Ann N Y Acad Sci 1139 2008 291 298
62. T. Crisp, J.L. Stafinsky, J.W. Boja, and M.D. Schechter The antinociceptive effects of MDMA in the rat Pharmacol Biochem Behav 34 1989 497 501
63. R.J. Croft, A.J. Mackay, A.T. Mills, and J.G. Gruzelier The relative contributions of ecstasy and cannabis to cognitive impairment Psychopharmacology (Berl). 153 2001 373 379 (Pubitemid 32125822)
64. H.G. Cruz, T. Ivanova, M.L. Lunn, M. Stoffel, P.A. Slesinger, and C. Luscher Bi-directional effects of GABA(B) receptor agonists on the mesolimbic dopamine system Nat Neurosci 7 2004 153 159 (Pubitemid 38129791)
65. H.V. Curran, and R.A. Travill Mood and cognitive effects of MDMA: weekend "high" followed by midweek low Addiction 92 1997 821 831
66. J.A. Dani, and M. De Biasi Cellular mechanisms of nicotine addiction Pharmacol Biochem Behav 70 2001 439 446 (Pubitemid 34131638)
67. E. Daniela, K. Brennan, D. Gittings, L. Hely, and S. Schenk Effect of SCH 23390 on 3,4-methylenedioxymethamphetamine hyperactivity and self administration in rats Pharmacol Biochem Behav 77 2004 745 750 (Pubitemid 38510285)
68. E. Daniela, D. Gittings, and S. Schenk Conditioning following repeated exposure to MDMA in rats: role in the maintenance of MDMA self-administration Behav Neurosci 120 2006 1144 1150 (Pubitemid 44584023)
69. J. Daumann, S. Pelz, S. Becke, F. Tuchtenhagen, and E. Gouzoulis-Mayfrank Psychological profile of abstinent recreational MDMA users and significance of concomitant cannabis use Hum Psychopharmacol 16 2001 627 633 (Pubitemid 34036944)
70. J. Daumann, G. Hensen, B. Thimm, M. Rezk, B. Till, and E. Gouzoulis-Mayfrank Self-reported psychopathological symptoms in recreational MDMA users are mainly associated with regular cannabis use: further evidence from a combined cross-sectional/longitudinal investigation Psychopharmacology (Berl). 173 2004 398 404 (Pubitemid 38703814)
71. D. Davison, and A.C. Parrott Ecstasy in recreational users: self-reported psychological and physiological effects Hum Psychopharmacol Clin Exp 12 1997 91 97
72. M. Daza-Losada, B. Ribeiro Do Couto, C. Manzanedo, M.A. Aguilar, M. Rodriguez-Arias, and J. Minarro Rewarding effects and reinstatement of MDMA-induced CPP in adolescent mice Neuropsychopharmacology 32 2007 1750 1759 (Pubitemid 47076389)
73. M. Daza-Losada, M. Rodriguez-Arias, M.A. Aguilar, and J. Minarro Effect of adolescent exposure to MDMA and cocaine on acquisition and reinstatement of morphine-induce CPP Prog Neuropsycho-pharmacol Biol Psychiatry. 32 2008 701 709 (Pubitemid 351312368)
74. M. Daza-Losada, M. Rodriguez-Arias, C. Maldonado, M.A. Aguilar, C. Guerri, and J. Minarro Acute behavioral and neurotoxic effects of MDMA plus cocaine in adolescent mice Neurotoxicol Teratol 31 2009 49 59
75. R. De la Torre, and M. Farre Neurotoxicity of MDMA (ecstasy): the limitation of scaling from animals to humans Trends Pharmacol Sci 25 2004 505 508 (Pubitemid 39233561)
76. R. De la Torre, M. Farre, J. Ortuno, M. Mas, R. Brenneisen, P.N. Roset, J. Segura, and J. Cami Non-linear pharmacokinetics of MDMA (ecstasy) in humans Br Clin Pharmacol. 49 2000 104 109 (Pubitemid 30068287)
77. S. De Sola, M. Miguelez-Pan, J. Pena-Casanova, S. Poudevida, M. Farree, R. Pacifini, P. Bohm, S. Abanades, A. Verdejo-Garcia, P. Zuccaro, and R. De La Torre Cognitive performance in recreational ecstasy polydrug users: a two-year follow up study J Psychopharmacol 200 2008 425 437
78. W. Dean, J. Morgenthaler, and S.W.M. Fowkes GHB: the natural mood enhancer 1997 Smart Publications Petaluma
79. L. Degenhardt, and W. Hall The relationship between tobacco use, substance-use disorders and mental health: results from the National Survey of Mental Health and Well-being Nicotine Tob Res 3 2001 225 234 (Pubitemid 32821650)
80. R.J. Devlin, and J.A. Henry Clinical review: major consequences of illicit drug consumption Crit Care 12 2008 202
81. M. Di Benedetto, C. D'addario, S. Candeletti, and P. Romualdi Chronic and acute effects of MDMA administration on the dynorphinergic system in the rat brain Neuroscience 137 2006 187 196 (Pubitemid 43031486)
82. A.J. Diller, A. Rocha, A.L. Cardon, R. Valles, P.J. Wellman, and J.R. Nation The effects of concurrent administration of +/-3,4- methylenedioxymethamphetamine and cocaine on conditioned place preference in the adult male rat Pharmacol Biochem Behav 88 2007 165 170 (Pubitemid 350116000)
83. P. Dillon, J. Copeland, and K. Jansen Patterns of use and harms associated with non-medical ketamine use Drug Alcohol Depend 2 2003 23 28 (Pubitemid 36110459)
84. J.R. Docherty, and A.R. Green The role of monoamines in the changes in body temperature induced by 3,4-methylenedioxymethamphetamine (MDMA, ecstasy) and its derivatives Br J Pharmacol 2010 1029 1044
85. S. Doyon The many faces of ecstasy Curr Opin Pediatr 13 2001 170 176 (Pubitemid 32382424)
86. E.S. Draper, J. Rankin, A.M. Tonks, K.R. Abrams, D.J. Field, M. Clarke, and J.J. Kurinczuk Recreational drug use: a major risk factor for gastroschisis? Am J Epidemiol 167 2008 485 491 (Pubitemid 351264151)
87. Drug Enforcement Administration (DEA), 2001. http://thedea.org/ statistics.html.
88. G.J. Dumont, E. Wezenberg, M.M. Valkenberg, C.A. de Jong, J.K. Buitelaar, J.M. van Gerven, and R.J. Verkes Acute neuropsychological effects of MDMA and ethanol (co)administration in healthy volunteers Psychopharmacology (Berl). 197 2008 465 474
89. G.J. Dumont, C. Kramers, F.C. Sweep, D.J. Touw, J.G. van Hasselt, M. de Kam, J.M. Gerven, J.K. Buitelaar, and R.J. Verkes Cannabis co-administration potentiates the effects of "ecstasy" on heart rate and temperature in humans Clin Pharmacol Ther 86 2009 160 166
90. G.J. Dumont, F.C. Sweep, R. van der Steen, R. Hermsen, A.R. Donders, D.J. Touw, J.M. van Gerven, J.K. Buitelaar, and R.J. Verkes Increased oxytocin concentrations and prosocial feelings in humans after ecstasy (3, 4-methylenedioxymethamphetamine) administration Soc Neurosci 4 2009 359 366
91. G.J. Dumont, R.C. Schoemaker, D.J. Touw, F.C. Sweep, J.K. Buitelaar, J.M. van Gerven, and R.J. Verkes Acute psychomotor effects of MDMA and ethanol (co-) administration over time in healthy volunteers J Psychopharmacol 24 2010 155 164
92. G.J. Dumont, C. Kramers, F.C. Sweep, J.J. Willemsen, D.J. Touw, R.C. Schoemaker, J.M. van Gerven, J.K. Buitelaar, and R.J. Verkes Ethanol co-administration moderates 3,4-methylenedioxymethamphetamine effects on human physiology J Psychopharmacol 24 2010 165 174
93. E. Duzel, W.D. Penny, and N. Burgess Brain oscillations and memory Curr Opin Neurobiol 20 2010 143 149
94. N. Easton, and C.A. Marsden Ecstasy: are animal data consistent between species and can they translate to humans? J Psycho-pharmacol. 20 2006 194 210
95. R.A. Ener, S.B. Meglathery, W.A. Van Decker, and R.M. Gallagher Serotonin syndrome and other serotonergic disorders Pain Med 4 2003 63 74
96. I. Escobedo, E. O'Shea, L. Orio, V. Sanchez, M. Segura, R. de la Torre, M. Farre, A.R. Green, and M.I. Colado A comparative study on the acute and long term effects of MDMA and 3,4-dihydroxymethamphetamine (HHMA) on brain monoamine levels after i.p. or striatal administration in mice Br J Pharmacol 144 2005 23 41
97. W.E. Fantegrossi, T. Godlewski, R.L. Karabenick, J.M. Stephens, T. Ullrich, K.C. Rice, and J.H. Woods Pharmacological characterization of the effects of 3,4-methylenedioxymethamphetamine ("ecstasy") and its enantiomers on lethality, core temperature, and locomotor activity in singly housed and crowded mice Psychopharmacology (Berl). 166 2003 202 211 (Pubitemid 36384765)
98. H.E. Felgate, P.D. Felgate, R.A. James, D.N. Sims, and D.C. Vozzo Recent paramethoxyamphetamine deaths J Anal Toxicol 22 1998 169 172 (Pubitemid 28128966)
99. J.J. Fernandez-Ruiz, R.M. Munoz, J. Romero, M.A. Villanua, A. Makriyannis, and J.A. Ramos Time course of the effects of different cannabimimetics on prolactin and gonadotrophin secretion: evidence for the presence of CB1 receptors in hypothalamic structures and their involvement in the effects of cannabimimetics Biochem Pharmacol 53 1997 1919 1927 (Pubitemid 27356065)
100. M. Fiege, F. Wappler, R. Weissborn, M.U. Gerbershagen, M. Menge, and J. Schulte Am Esch Induction of malignant hyperthermia in susceptible swine by 3,4 methylenedioxymethamphetamine (ecstasy) Anesthesiology 99 2003 1132 1136 (Pubitemid 37339459)
101. H.S. Fischer, G. Zernig, D.S. Schatz, C. Humpel, and A. Saria MDMA ('ecstasy') enhances basal acetylcholine release in brain slices of the rat striatum Eur J Neurosci 12 2000 1385 1390 (Pubitemid 30224241)
102. J.E. Fisk, C. Montgomery, M. Wareing, and P.N. Murphy The effects of concurrent cannabis use among ecstasy users: neuroprotective or neurotoxic? Hum Psychopharmacol 21 2006 355 366 (Pubitemid 44355614)
103. P.J. Fletcher, S.R. Robinson, and D.L. Slippoy Pre-exposure to (+/-)3,4-methylenedioxy-methamphetamine (MDMA) facilitates acquisition of intravenous cocaine self-administration in rats Neuropsychopharmacology 25 2001 195 203 (Pubitemid 32566341)
104. P.J. Fletcher, J. Sinyard, and G.A. Higgins The effects of the 5-HT2C receptor antagonist SB242084 on locomotor activity induced by selective, or mixed, indirect serotonergic and dopaminergic agonists Psychopharmacology 187 2006 515 525 (Pubitemid 44200523)
105. F. Fornai, P. Lenzi, G. Frenzilli, M. Gesi, M. Ferrucci, G. Lazzeri, F. Biagioni, M. Nigro, A. Falleni, M. Giusiani, A. Pellegrini, F. Blandini, S. Ruggieri, and A. Paparelli DNA damage and ubiquitinated neuronal inclusions in the substantia nigra and striatum of mice following MDMA (ecstasy) Psychopharmacology 173 2004 353 363 (Pubitemid 38703809)
106. M. Forsling, J.K. Fallon, A.T. Kicman, A.J. Hutt, D.A. Cowan, and J.A. Henry Arginine vasopressin release in response to the administration of 3,4-methylenedioxymethamphetamine ("ecstasy"): is metabolism a contributory factor? J Pharm Pharmacol 53 2001 1357 1363 (Pubitemid 32982252)
107. R.R. Freedman, C.E. Johnson, and M.E. Tancer Thermoregulatory effects of 3,4 methylenedioxymethamphetamine (MDMA) in humans Psychopharmacology (Berl). 183 2005 248 256 (Pubitemid 41609277)
108. G. Frenzilli, M. Ferrucci, F.S. Giorgi, F. Blandini, M. Nigro, S. Ruggieri, L. Murri, A. Paparelli, and F. Fornai DNA fragmentation and oxidative stress in the hippocampal formation: a bridge between 3,4- methylenedioxymethamphetamine (ecstasy) intake and long-lasting behavioral alterations Behav Pharmacol 18 2007 471 481 (Pubitemid 47356373)
109. L. Galineau, C. Belzung, E. Kodas, S. Bodard, D. Guilloteau, and S. Chalon Prenatal 3,4 methylenedioxymethamphetamine (ecstasy) exposure induces long-term alterations in dopaminergic and serotonergic functions in the rat Brain Res. Dev. Brain Res. 154 2005 165 176 (Pubitemid 40221861)
110. J. Gerevich, E. Bácskai, M.F. Kerekes, N. Kiss, and J. Csorba Combination of heroin and Ecstasy with fatal outcome: contribution on the question of harms arising from the combination of drugs Psychiatr Hung 15 2000 583 586
111. G. Gerra, A. Zaimovic, M. Ferri, U. Zambelli, M. Timpano, E. Neri, G.F. Marzocchi, R. Delsignore, and F. Brambilla Long-lasting effects of 3,4-methylenedioxymethamphetamine (ecstasy) on serotonin system function in humans Biol Psychiatry 47 2000 127 136 (Pubitemid 30069736)
112. M. Gervin, R. Smith, L. Bamford, and E. Keenan Chasing the dragon: experience in Ireland and association with ecstasy Addiction 93 1998 601 603
113. M. Gervin, R. Hughes, L. Bamford, B.P. Smyth, and E. Keenan Heroin smoking by chasing the dragon in young opiate users in Ireland: stability and associations with use to come down off ecstasy J Subst Abuse Treat 20 2001 297 300 (Pubitemid 32717593)
114. A.C. Glatz, M. Ehrlich, R.S. Bae, M.J. Clarke, P.A. Quinlan, E.C. Brown, P. Rada, and B.G. Hoebel Inhibition of cocaine self-administration by fluoxetine or d-fenfluramine combined with phentermine Pharmacol Biochem Behav 71 2002 197 204 (Pubitemid 34102479)
115. S. Gobaille, C. Schleef, V. Hechler, S. Viry, D. Aunis, and M. Maitre Gamma-hydroxybutyrate increases tryptophan availability and potentiates serotonin turnover in rat brain Life Sci 70 2002 2101 2112 (Pubitemid 34219461)
116. A. Golub, B.D. Johnson, S.J. Sifaneck, B. Chesluk, and H. Parker Is the US experiencing an incipient epidemic of hallucinogen use? Subst Use Misuse 36 2001 1699 1729 (Pubitemid 33095914)
117. A.K. Goodwin, and L.E. Baker A three-choice discrimination procedure dissociates the discriminative stimulus effects of d-amphetamine and (+/-)-MDMA in rats Exp Clin Psychopharmacol 8 2000 415 423
118. E. Gouzoulis-Mayfrank, J. Daumann, F. Tuchtenhagen, S. Pelz, S. Becker, H.J. Kunert, B. Fimm, and H. Sass Impaired cognitive performance in drug free users of recreational ecstasy (MDMA) J Neurol Neurosurg Psychiatry 68 2000 719 725 (Pubitemid 30265271)
119. E. Gouzoulis-Mayfrank, S. Becker, S. Pelz, F. Tuchtenhagen, and J. Daumann Neuroendocrine abnormalities in recreational ecstasy (MDMA) users: is it ecstasy or cannabis? J Biol Psychiatry. 51 2002 766 769 (Pubitemid 34450813)
120. N. Granado, I. Escobedo, E. O'Shea, I. Colado, and R. Moratalla Early loss of dopaminergic terminals in striosomes after MDMA administration to mice Synapse 62 2008 80 84 (Pubitemid 350156147)
121. N. Granado, E. O'Shea, J. Bove, M. Vila, M.I. Colado, and R. Moratalla Persistent MDMA-induced dopaminergic neurotoxicity in the striatum and substantia nigra of mice J Neurochem 107 2008 1102 1112
122. A.R. Green, A.J. Cross, and G.M. Goodwin Review of the pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA or "Ecstasy") Psychopharmacology (Berl). 119 1995 247 260
123. A.R. Green, A.O. Mechan, J.M. Elliott, E. O'Shea, and M.I. Colado The pharmacology and clinical pharmacology of 3,4-methylenedioxymethamphetamine (MDMA, 'ecstasy') Pharmacological Review. 55 2003 463 508 (Pubitemid 37013213)
124. S.R. Gross Ecstasy and drug consumption patterns: a Canadian rave population study Can J Psychiatry 47 2002 546 551
125. R.I. Grundy The therapeutic potential of the cannabinoids in neuroprotection Expert Opin Invest Drugs. 11 2002 1365 1374 (Pubitemid 35174935)
126. G.A. Gudelsky, and J.F. Nash Carrier mediated release of serotonin by MDMA: implications for serotonin-dopamine interactions J Neurochem 66 1996 243 249
127. A.P. Hall, and J.A. Henry Acute toxic effects of Ecstasy (MDMA) and related compounds: overview of pathophysiology and clinical management Br J Anaesth 96 2006 678 685 (Pubitemid 43786681)
128. S.B. Hamida, A. Tracqui, A.P. de Vasconcelos, E. Szwarc, C. Lazarus, C. Kelche, B.C. Jones, and J.C. Cassel Ethanol increases the distribution of MDMA to the rat brain: possible implications in the ethanol-induced potentiation of the psychostimulant effects of MDMA Int J Neuropsychopharmacol 12 2009 749 759
129. D.D. Han, and H.H. Gu Comparison of the monoamine transporters from human and mouse in their sensitivities to psychostimulant drugs BMC Pharmacol 6 2006 6
130. K.L. Hanson, and M. Luciana Neurocognitive impairments in MDMA and other drug users: MDMA alone may not be a cognitive risk factor J Clin Exp Neuropsychol 32 2010 337 349
131. G.R. Hanson, K.S. Rau, and A.E. Fleckenstein The methamphetamine experience: a NIDA partnership Neuropharmacology 47 2004 92 100 (Pubitemid 39298255)
132. C.L. Hart, A.S. Ward, M. Haney, R.W. Foltin, and M.W. Fischman Methamphetamine self-administration by humans Psychopharmacology (Berlin). 157 2001 75 81 (Pubitemid 32758962)
133. K. Hayakawa, K. Mishima, K. Abe, N. Hasebe, F. Takamatsu, H. Yasuda, T. Ikeda, K. Inui, N. Egashira, K. Iwasaki, and M. Fujiwara Cannabidiol prevents infarction via the non-CB1 cannabinoid receptor mechanism Neuro Report. 25 2004 2381 2385 (Pubitemid 39488924)
134. K.M. Hegadoren, G.B. Baker, and M. Bourin 3,4-Methylenedioxy analogues of amphetamine: defining the risks to humans Neurosci Biobehav Rev 23 1999 539 553 (Pubitemid 29086923)
135. C.R. Hekmatpanah, and S.J. Peroutka 5-Hydroxytryptamine uptake blockers attenuate the 5-hydroxytryptamine releasing effect of 3,4- methylenedioxymethamphetamine and related agents Eur J Pharmacol 177 1990 95 98 (Pubitemid 20077957)
136. J.A. Henry, K.J. Jeffreys, and S. Dawling Toxicity and deaths from MDMA Lancet 340 1992 384 387
137. C. Hernandez-Lopez, M. Farre, P.N. Roset, E. Menoyo, N. Pizarro, J. Ortuno, M. Torrens, J. Cami, and R. de La Torre MDMA and alcohol interactions in humans: psychomotor performance, subjective effects and pharmacokinetics JPET. 300 2002 236 244 (Pubitemid 34028533)
138. V. Hernandez-Rabaza, G. Navarro-Mora, C. Velazquez-Sanchez, A. Ferragud, M.P. Marin, J.M. Garcia-Verdugo, J. Renau-Piqueras, and J.J. Canales Neurotoxicity and persistent cognitive deficits induced by combined MDMA and alcohol exposure in adolescent rats Addict Biol 15 2010 413 423
139. E. Heuland, M.A. Germauz, L. Galineau, S. Chalon, and C. Belzung Prenatal MDMA exposure delays postnatal development in the rat: a preliminary study Neurotoxicol Teratol 32 2010 425 431
140. E. Ho, L. Karimi-Tabesh, and G. Koren Characteristics of pregnant women who use ecstasy (3, 4-methylenedioxymethamphetamine) Neurotoxicol Teratol 23 2001 561 567 (Pubitemid 34132930)
141. C. Hopfer, B. Mendelson, J.M. Van Leeuwen, S. Kelly, and S. Hooks Club drug use among youths in treatment for substance abuse Am J Addict 15 2006 94 99 (Pubitemid 43207194)
142. B. Horan, E.L. Gardner, and C.R. Ashby Jr. Enhancement of conditioned place preference response to cocaine in rats following subchronic administration of 3,4-methyldioxymethamphetamine (MDMA) Synapse 35 2000 160 162 (Pubitemid 30036193)
143. S.G. Howard, and P.K. Banerjee Regulation of central dopamine by GHB G. Tunnicliff, C.D. Cash, GHB 2002 Taylor & Francis London 111 119
144. L.L. Howell, and L.D. Byrd Serotonergic modulation of the behavioral effects of cocaine in the squirrel monkey J Pharmacol Exp Ther 275 1995 1551 1559 (Pubitemid 26129947)
145. C.B. Hubner, M. Bird, S. Rassnick, and C. Kornetsky The threshold lowering effects of MDMA (ecstasy) on brain stimulation reward Psychopharmacology (Berl). 95 1988 49 51
146. F. Indlekofer, M. Piechatzek, M. Daamen, C. Glasmacher, R. Lieb, H. Pfister, O. Tucha, K.W. Lange, H.U. Wittchen, and C.G. Schütz Reduced memory and attention performance in a population-based sample of young adults with a moderate lifetime use of cannabis, ecstasy and alcohol J Psychopharmacol 23 2009 495 509
147. K.L. Jansen Non-medical use of ketamine BMJ 306 1993 601 602 (Pubitemid 23065819)
148. S.S. Johansen, A.C. Hansen, I.B. Müller, J.B. Lundemose, and M.B. Franzmann Three fatal cases of PMA and PMMA poisoning in Denmark J Anal Toxicol 27 2003 253 256 (Pubitemid 36666836)
149. M. Johnson, L.G. Bush, J.W. Gibb, and G.R. Hanson Blockade of the 3,4-methylenedioxymethamphetamine-induced changes in neurotensin and dynorphin A systems Eur J Pharmacol 193 1991 367 370
150. E.A. Johnson, J.P. O'Callaghan, and D.B. Miller Brain concentrations of d-MDMA are increased after stress Psychopharmacology (Berlin). 173 2004 278 286 (Pubitemid 38703801)
151. B.C. Jones, S. Ben-Hamida, A.P. de Vasconcelos, C. Kelche, C. Lazarus, R. Jackisch, and J.C. Cassel Effects of Ethanol and ecstasy on conditioned place preference in the rat J Psychopharmacol 24 2010 275 279
152. A. Kaizaki, S. Tanaka, K. Tsujikawa, S. Numazawa, and T. Yoshida Recreational drugs, 3,4-Methylenedioxymethamphetamine(MDMA), 3,4-methylenedioxyamphetamine (MDA) and diphenylprolinol, inhibit neurite outgrowth in PC12 cells J Toxicol Sci 35 2010 375 381
153. P.W. Kalivas, P. Duffy, and S.R. White MDMA elicits behavioral and neurochemical sensitization in rats Neuropsychopharmacology 18 1998 469 479 (Pubitemid 28202354)
154. S. Kaye, S. Darke, and J. Duflou Methylenedioxymethamphetamine (MDMA)-related fatalities in Australia: demographics, circumstances, toxicity and major organ pathology Drug Alcohol Depend 104 2009 254 261
155. J.J. Ke, M.C. Ho, C.G. Cherng, Y.P. Tsai, C.W. Tsai, and L. Yu Ketamine pretreatment exacerbated MDMA-induced central dopamine toxicity Chin J Phsiol. 51 2008 65 70
156. S.J. Kish, J. Lerch, Y. Furukawa, J. Tong, T. McCluskey, D. Wilkins, S. Houle, J. Meyer, E. Mundo, A.A. Wislon, P.M. Rusjan, J.A. Saint-Cyr, M. Guttman, D.L. Collins, C. Shapiro, J.J. Warsh, and I. Boileau Decreased cerebral cortical serotonin transporter binding in ecstasy users: a positron emission tomography/[(11)C]DASB and structural brain imaging study Brain 133 2010 1779 1797
157. W. Klingler, J.J. Heffron, K. Jurkat-Rott, G. O'sullivan, A. Alt, F. Schlesinger, J. Bufler, and F. Lehmann-Horn 3,4-Methylenedioxymethamphetamine (ecstasy) activates skeletal muscle nicotinic acetylcholine receptors J Pharmacol Exp Ther 314 2005 1267 1273 (Pubitemid 41205993)
158. S.C. Koesters, P.D. Rogers, and C.R. Rajasingham MDMA and other club drugs. The new epidemic Pediatr Clin North Am 49 2002 415 433 (Pubitemid 34441068)
159. E.A. Kolbrich, R.S. Goodwin, da Gorelick, R.J. Hayes, E.A. Stein, and M.A. Huestis Physiological and subjective responses to controlled oral MDMA administration J Clin Psychopharmacol 28 2008 432 440
160. J.B. Koprich, E.Y. Chen, N.M. Kanaan, N.G. Campbell, J.H. Kordower, and J.W. Lipton Prenatal 3, 4-methylenedioxymethamphetamine (ecstasy) alters exploratory behaviour, reduces monoamine metabolism, and increases forebrain tyrosine hydroxylase fiber density of juvenile rats Neurotoxicol Teratol 25 2003 509 517 (Pubitemid 37103049)
161. J.C. Kraner, D.J. McCoy, M.A. Evans, L.E. Evans, and B.J. Sweeney Fatalities caused by the MDMA-related drug paramethoxyamphetamine (PMA) J Anal Toxicol 25 2001 645 648 (Pubitemid 32939075)
162. H. Kuribara, H. Sekine, and Y. Nakahara Characteristics of behavioural stimulant effect of N-cyanomethylmethamphetamine, a main product of smoking methamphetamine mixed with tobacco: evaluation by ambulatory activity in mice Pharmacol Toxicol 78 1996 374 380 (Pubitemid 26226647)
163. K.P. Kuypers, N. Samyn, and J.G. Ramaekers MDMA and alcohol effects, combined and alone, on objective and subjective measures of actual driving performance and psychomotor function Psychopharmacology (Berl). 187 2006 467 475 (Pubitemid 44200518)
164. C.T. Lamers, A. Bechara, M. Rizzo, and J.G. Ramaekers Cognitive function and mood in MDMA/THC users, THC users and non-drug using controls J Psychopharmacol 20 2006 302 311
165. M.M. Lansbergen, G.J. Dumont, J.M. van Gerven, J.K. Buitelaar, and R.J. Verkes Acute effects of MDMA (3,4-methylenedioxymethamphetamine) on EEG oscillations: alone and in combination with ethanol or THC (delta-9- tetrahydrocannabinol) Psychopharmacology (Berl). 213 2011 745 756
166. S.J. Lee, and P. Levounis Gamma hydroxybutyrate: an ethnographic study of recreational use and abuse J Psychoactive Drugs 40 2008 245 253
167. M.R. Lee, J. Jeng, W.S. Hsiang, and B.H. Hwang Determination of pyrolysis products of smoked methamphetamine mixed with tobacco by tandem mass spectrometry J Anal Toxicol 23 1999 41 45 (Pubitemid 29327452)
168. R. Lew, K.E. Sabol, C. Chou, G.L. Vosmer, J. Richards, and L.S. Seiden Methylenedioxymethamphetamine-induced serotonin deficits are followed by partial recovery over a 52-week period. Part II: radioligand binding and autoradiography studies J Pharmacol Exp Ther 276 1996 855 865
169. R. Lieb, C.G. Schuetz, H. Pfister, K. von Sydow, and H. Witchen Mental disorders in ecstasy users: a prospective-longitudinal investigation Drug Alcohol Depend 68 2002 195 207 (Pubitemid 35247791)
170. M.E. Liechti, and F.X. Vollenweider Acute psychological and physiological effects of MDMA ("Ecstasy") after haloperidol pretreatment in healthy humans Eur Neuropsychopharmacol 10 2000 289 295 (Pubitemid 30394604)
171. M.E. Liechti, and F.X. Vollenweider The serotonin uptake inhibitor citalopram reduces acute cardiovascular and vegetative effects of 3,4-methylenedioxymethamphetamine ('Ecstasy') in healthy volunteers J Psychopharmacol 14 2000 269 274
172. M.E. Liechti, C. Baumann, A. Gamma, and F.X. Vollenweider Acute psychological effects of 3,4-methylenedioxymethamphetamine (MDMA, "Ecstasy") are attenuated by the serotonin uptake inhibitor citalopram Neuropsychopharmacology 22 2000 513 521 (Pubitemid 30145619)
173. M.E. Liechti, M.R. Saur, A. Gamma, D. Hell, and F.X. Vollenweider Psychological and physiological effects of MDMA ("Ecstasy") after pretreatment with the 5HT(2) antagonist ketanserin in healthy humans Neuropsychopharmacology 23 2000 396 404
174. J.A. Lile, J.T. Ross, and M.A. Nader A comparison of the reinforcing efficacy of MDMA with cocaine in rhesus monkeys Drug Alcohol Depend 78 2005 135 140
175. H.Q. Lin, D.M. Jackson, D.M. Atrens, M.J. Christie, and I.S. McGregor Serotonergic modulation of 3,4-methylenedioxymethamphetamine (MDMA)-elicited reduction of response rate but not rewarding threshold in accumbal self-stimulation Brain Res 744 1997 351 357 (Pubitemid 27032355)
176. L.H. Ling, C. Marchant, N.A. Buckley, M. Prior, and R.J. Irvine Poisoning with the recreational drug paramethoxyamphetamine ("death") Med J Aust 174 2001 453 455 (Pubitemid 32466069)
177. C. Lora-Tamayo, T. Tena, A. Rodriguz, D. Moreno, and J.R. Sancho The designer drug situation in Ibiza Forensic Sci Int 140 2004 195 206 (Pubitemid 38230054)
178. J. Lyles, and J.L. Cadet Methylenedioxymethamphetamine [MDMA, ecstasy] neurotoxicity: cellular and molecular mechanisms Brain Res Brain Res Rev 42 2003 155 168 (Pubitemid 36549174)
179. M. Maitre, J.P. Humbert, V. Kemmel, D. Aunis, and C. Andriamampandry A mechanism for GHB as a drug and a substance of abuse Med Sci (Paris). 3 2005 284 289 (Pubitemid 40396208)
180. Y. Makino, S. Tanaka, S. Kurobane, M. Nakauchi, T. Terasaki, and S. Ohta Profiling of illegal amphetamine-type stimulant tablet in Japan J Health Sci. 49 2003 129 137 (Pubitemid 41301480)
181. T.L. Martin Three cases of fatal paramethoxyamphetamine overdose J Anal Toxicol 25 2001 649 651 (Pubitemid 32939076)
182. S.S. Martins, G. Mazzotti, and H.D. Chilcoat Trends in ecstasy use in the USA from 1995 to 2001: comparison with marijuana and association with other drug use Exp Clin Psychopharmacol 13 2005 244 252 (Pubitemid 41330638)
183. S.S. Martins, G. Mazzotti, and H.D. Chilcoat Recent onset ecstasy users: association with other drug use, psychiatric comorbidity and deviant behaviors Exp Clin Psychopharmacol 14 2006 275 286 (Pubitemid 44267471)
184. S.S. Martins, L.A. Ghandour, and H.D. Chilcoat Pathways between ecstasy initiation and other drug use Addict Behav 32 2007 1511 1518 (Pubitemid 46656314)
185. S.S. Martins, C.L. Storr, P.K. Alexandre, and H.D. Chilcoat Adolescent ecstasy and other drug use in the National Survey of Parents and Youth: the role of sensation-seeking, parental monitoring and peer's drug use Addict Behav 33 2008 919 933
186. A. Mayerhofer, K.A. Kovar, and W.J. Schmidt Changes in serotonin, dopamine and noradrenaline levels in striatum and nucleus accumbens after repeated administration of the abused drug MDMA in rats Neurosci Lett 308 2001 99 102 (Pubitemid 32703677)
187. J. McClung, W. Fantegrossi, and L.L. Howell Reinstatement of extinguished amphetamine self-administration by MDMA and its enantiomers in rhesus monkeys Psychopharmacology (Berl). 210 2010 75 83
188. P.R. McElhatton, D.N. Bateman, C. Evans, K.R. Pughe, and A.J. Worsley Does prenatal exposure to ecstasy cause congenital malformations? A prospective follow-up of 92 pregnancies Br J Clin Pharmacol 45 1997 184
189. P.R. McElhatton, D.N. Baterman, C. Evans, K.R. Pughe, and S.H. Thomas Congenital anomalies after prenatal ecstasy exposure Lancet 354 1999 1141 1142
190. I.S. McGregor, K.J. Clemens, G. Van der Plasse, K.M. Li, G.E. Hunt, F. Chen, and A.J. Lawrence Increased anxiety 3 months after brief exposure to MDMA ("Ecstasy") in rats: association with altered 5-HT transporter and receptor density Neuropsychopharmacology 28 2003 1472 1484 (Pubitemid 41070882)
191. R. McNamara, A. Kerans, B. O'Neill, and A. Harkin Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love") Neuropharmacology 50 2006 69 80 (Pubitemid 43069773)
192. R. McNamara, M. Maginn, and A. Harkin Caffeine induces a profound and persistent tachycardia in response to MDMA administration Eur J Pharmacol 555 2007 194 198 (Pubitemid 46048811)
193. A.O. Mechan, E. O'Shea, J.M. Elliot, M.I. Colado, and A.R. Green A neurotoxic dose of 3, 4-methylenedioxymethamphetamine (MDMA; ecstasy) to rats results in a long-term defect in thermoregulation Psychopharmacology 155 2001 413 418 (Pubitemid 32523112)
194. R.R. Metzger, G.R. Hanson, J.W. Gibb, and A.E. Fleckenstein 3, 4-Methylenedioxymethamphetamine-induced acute changes in dopamine transporter function Eur J Pharmacol 349 1998 205 210 (Pubitemid 28277089)
195. R.M. Milani, A.C. Parrott, F. Scgifano, and J.J.D. Turner Pattern of cannabis use in ecstasy polydrug users: moderate cannabis use may compensate for self-rated aggression and somatic symptoms Humn Psychopharmacol Clin Exp. 20 2005 249 261 (Pubitemid 40873463)
196. N.S. Miller, and M.S. Gold LSD and ecstasy: pharmacology, phenomerology and treatment Psychiat Annals. 24 1994 131 133
197. R.B. Millman, and A.B. Beeder The new Psychedelic culture: LSD, ecstasy, 'rave' parties and the Grateful Dead Psychiat. Annals. 24 1994 148 150
198. G.M. Modi, P.B. Yang, A.C. Swann, and N. Dafny Chronic exposure to MDMA elicits behavioral sensitization in rats but fails to induce cross-sensitization to other psychostimulants Behav Brain Funct 2 2006 1
199. W.M. Mohamed, S.B. Hamida, A.P. de Vasconcelos, J.C. Cassel, and B.C. Jones Interactions between 3,4-methylenedioxymethamphetamine and ethanol in humans and rodents Neuropsychobiology 60 2009 188 194
200. A.E. Morgan, B. Horan, S.L. Dewey, and C.R. Ashby Jr. Repeated administration of MDMA augments cocaine's action on dopamine in the nucleus accumbens: a microdialysis study Eur J Pharmacol 331 1997 R1 R3
201. M.J. Morgan, L. McFie, H. Fleetwood, and J.A. Robinson Ecstasy: are the psychological problems associated with its use reversed by prolonged abstinence? Psychopharmacology (Berl). 159 2002 294 303 (Pubitemid 34143378)
202. K.C. Morley, K.M. Li, G.E. Hunt, P.E. Maller, and I.S. McGregor Cannabinoids prevent the acute hyperthermia and partially protect against the 5-HT depleting effects of MDMA in rats Neuropharmacology 46 2004 954 965 (Pubitemid 38471949)
203. K.C. Morley, J.L. Cornish, K.M. Li, and I.S. McGregor Preexposure to MDMA ("Ecstasy") delays acquisition but facilitates MDMA-induced reinstatement of amphetamine self-administration behavior in rats Pharmacol Biochem Behav 79 2004 331 342 (Pubitemid 40029237)
204. S.G. Nair, and G.A. Gudelsky MDMA enhances the release of Ach in the prefrontal cortex and dorsal hippocampus of the rat Psychopharmacol (Berl). 184 2006 182 189 (Pubitemid 43083655)
205. National Institute on Drug Abuse. Methamphetamine abuse alert. NIDA Notes 13(6), tearoff. March, 1999 [Access July 02, 2010]. From http://archives. drugabuse.gov/NIDA-Notes/NNVol13N6/tearoff.html
206. J.F. Navarro, G. Davila, C. Pedraza, and J.L. Arias Anxiogenic-like effects of gamma-hydroxybutyric acid (GHB) in mice tested in the light-dark box Psicothema 20 2008 460 464
207. E.J. Nestler Is there a common molecular pathway for addiction? Nat Neurosci 8 2005 1445 1449 (Pubitemid 41573654)
208. K.L. Nicholson, and R.L. Balster GHB: a new and novel drug of abuse Drug Alcohol Depend 63 2001 1 22 (Pubitemid 32288730)
209. NSDUH Results from the 2009 National Survey on Drug Use and Health Summary of National Findings Volume 1 2010 (September, 2010). http://www.oas.samhsa.gov/NSDUH/2k9NSDUH/2k9ResultsP.pdf
210. E. O'Shea, L. Orio, I. Escobedo, V. Sanchez, J. Camarero, A.R. Green, and M.I. Colado MDMA-induced neurotoxicity: long-term effects on 5-HT biosynthesis and the influence of ambient temperature Br J Pharmacol 148 2006 778 785 (Pubitemid 44079407)
211. R. Oberlender, and D.E. Nichols Drug discrimination studies with MDMA and amphetamine Psychopharmacology (Berl.). 95 1988 71 76
212. J.R. Oesterheld, S.C. Armstrong, and K.L. Cozza Ecstasy: pharmacodynamic and pharmacokinetic interactions Psychosomatics 45 2004 84 87 (Pubitemid 38087946)
213. M. Okada, K. Kiryu, Y. Kawata, K. Mizuno, K. Wada, H. Tasaki, and S. Kaneko Determination of the effects of caffeine and carbamazepine on striatal dopamine release by in vivo microdialysis Eur J Pharmacol 321 1997 181 188 (Pubitemid 27089549)
214. M.J. Orejarena, F. Berrendero, R. Maldonado, and P. Robledo Differential changes in mesolimbic dopamine following contingent and non-contingent MDMA self-administration in mice Psychopharmacology (Berl). 205 2009 457 466
215. R. Pacifici, P. Zuccaro, M. Farre, S. Pichini, S. Di Carlo, P.N. Roser, I. Palmi, J. Ortuño, E. Menoyo, J. Segura, and R. de la Torre Cell-mediated immune response in MDMA users after repeated dose administration: studied in controlled versus non-controlled settings Ann N Y Acad Sci 965 2002 421 433 (Pubitemid 34721989)
216. R. Pacifici, P. Zuccaro, M. Farre, S. Poudevida, S. Abanades, S. Pichini, K. Langohr, and R. de la Torre Combined immunomodulating properties of 3,4-methylenedioxymethamphetamine (MDMA) and cannabis in humans Addiction 102 2007 931 936 (Pubitemid 46802231)
217. J.J. Panos, and L.E. Baker An in vivo microdialysis assessment of concurrent MDMA and cocaine administration in Sprague-Dawley rats Psychopharmacology (Berl). 209 2010 95 102
218. A.C. Parrott Does cigarette smoking cause stress? Am Psychol 54 1999 817 820
219. A.C. Parrott Human psychopharmacology of ecstasy (MDMA): a review of 15 years of empirical research Human Psychopharmacology Clinical and Experimental. 16 2001 557 577 (Pubitemid 34040989)
220. A.C. Parrott Nicotine-derived nicotine is not a medicine World J Biol Psychiatry 4 2003 49 55
221. A.C. Parrott Is Ecstasy MDMA? A review of the proportion of ecstasy tablets containing MDMA, dosage levels, and the changing perceptions of purity Psychopharmacology 173 2004 234 241 (Pubitemid 38703796)
222. A.C. Parrott Polydrug use amongst recreational cannabis and Ecstasy/MDMA uses: pharmacodynamic reasons and neuropsychiatric implications World J Biol Psychiatry 5 2004 108
223. A.C. Parrott Chronic tolerance to recreational MDMA (3,4- methylenedioxymethamphetamine) or Ecstasy J Psychopharmacol 19 2005 71 83
224. A.C. Parrott MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress J Psychopharmacol 20 2006 146 162
225. A.C. Parrott, A. Lees, N.J. Garnham, M. Jones, and K. Wesnes Cognitive performance in recreational users of MDMA or "ecstasy": evidence for memory deficits J Psychopharmacol 12 1998 79 83 (Pubitemid 28143002)
226. A.C. Parrott, E. Sisk, and J.J.D. Turner Psychobiological problems in heavy 'Ecstasy' (MDMA) polydrug users Drug Alcohol Depend 60 2000 105 110 (Pubitemid 30255991)
227. A.C. Parrott, E. Gouzoulis-Meyfrank, J. Rodgers, and N. Solowij Ecstasy/MDMA and cannabis: the complexities of their interactive neuropsychobiological effects J Psychopharmacol 18 2004 572 575 (Pubitemid 39665126)
228. A.C. Parrott, J. Margetson, J. Thome, and Christian. Cigarette, ecstasy and the inverse pleasure: nicotine abstinence effects in recreational ecstasy/MDMA users J Psychopharm. 19 2005 a27
229. A.C. Parrott, R.M. Milani, E. Gouzoulis-Mayfrank, and J. Daumann Cannabis and Ecstasy/MDMA (3,4-methylenedioxymethamphetamine): an analysis of their neuropsychobiological interactions in recreational users J Neural Transm 114 2007 959 968 (Pubitemid 47106452)
230. A.C. Parrott, J. Lock, A.C. Conner, C. Kissling, and J. Thome Dance clubbing on-MDMA and during abstinence from MDMA: prospective neuroendocrine and psychobiological changes Neuropsychobiology 57 2008 165 180
231. J.S. Partilla, A.G. Dempsey, A.S. Nagpal, B.E. Blough, M.H. Baumann, and R.B. Rothman Interaction of amphetamines and related compounds at the vesicular monoamine transporter J Pharmacol Exp Ther 319 2006 237 246 (Pubitemid 44455128)
232. N.P. Pedersen, and W.W. Blessing Cutaneous vasoconstriction contributes to hyperthermia induced by 3,4-methylenedioxymethamphetamine (ecstasy) in conscious rabbits J Neurosci 21 2001 8648 8654 (Pubitemid 33051462)
233. W. Pedersen, and A. Skrondal Ecstasy and new patterns of drug use: a normal population study Addiction 94 1999 1695 1706
234. C. Pedraza, F.B. Garcia, and J.F. Navarro Neurotoxic effects induced by gammahydroxybutyric acid (GHB) in male rats Int J Neuropsychopharmacol 12 2009 1165 1177
235. M. Perez-Reyes, W.R. White, S.A. McDonald, and R.E. Hicks Interaction between ethanol and dextroamphetamine: effects on psychomotor performance Alcohol Clin Exp Res 16 1992 75 81
236. M.R. Picciotto Nicotine as a modulator of behavior: beyond the inverted U Trends Pharmacol Sci 24 2003 493 499 (Pubitemid 37088175)
237. B.J. Piper A developmental comparison of the neurobehavioral effects of ecstasy (MDMA) Neurotoxicol Teratol 29 2007 288 300 (Pubitemid 46400368)
238. D. Pubill, A.M. Canudas, M. Pallas, A. Camins, J. Camarasa, and E. Escubedo Different glial response to methamphetamine- and methylenedioxymethamphetamine-induced neurotoxicity Naunyn-Schmiedeberg's Arch. Pharmacol. 367 2003 490 499 (Pubitemid 36718300)
239. J.G. Ramaekers, and K.P. Kuypers Acute effects of 3,4- methylenedioxymethamphetamine (MDMA) on behavioral measures of impulsivity: alone and in combination with alcohol Neuropsychopharmacology 31 2006 1048 1055
240. Y. Ramamoorthy, A.M. Yu, N. Suh, R.L. Haining, R.F. Tyndale, and E.M. Sellers Reduced MDMA metabolism with cytochrome P450 2D6 inhibitors and pharmacogenetic variants in vitro Biochem Pharmacol 63 2002 2111 2119
241. E. Ratzenboeck, A. Saria, N. Kriechbaum, and G. Zernig Reinforcing effects of MDMA ("ecstasy") in drug-naive and cocaine-trained rats Pharmacology 62 2001 138 144 (Pubitemid 32260853)
242. L.D. Reid, C.L. Hubbell, J. Tsai, M.D. Fishkin, and C.A. Amendola Naltrindole, a delta-opioid antagonist, blocks MDMA's ability to enhance pressing for rewarding brain stimulation Pharmacol Biochem Behav 53 1996 477 480
243. L. Reneman, J. Booij, J. Lavalaye, K. de Bruin, J.B. Reitsma, B. Gunning, G.J. den Heeten, and W. van Den Brink Use of amphetamine by recreational users of ecstasy (MDMA) is associated with reduced striatal dopamine transporter densities: a [123I] beta-CIT SPECT study-preliminary report Psychopharmacology (Berlin). 159 2002 335 340 (Pubitemid 34143383)
244. L. Reneman, M.M. de Win, W. van den Brink, J. Booij, and G.J. den Heeten Neuroimaging findings with MDMA/ecstasy: technical aspects, conceptual issues and future prospects J Psychopharmacol 20 2006 164 175
245. M.E. Reveron, E.Y. Maier, and C.L. Duvauchelle Behavioral, thermal and neurochemical effects of acute and chronic ecstasy self-administration Behav Brain Res 207 2010 500 507
246. B. Ribeiro Do Couto, M. Rodriguez-Arias, S. Fuentes, H. Gagliano, A. Armarioa, J. Miñarro, and M.A. Aguilar Adolescent pre-exposure to ethanol or MDMA prolongs the conditioned rewarding effects of MDMA Physiol Behav 103 2011 585 593
247. M.E. Rice, and S.J. Cragg Nicotine amplifies reward-related dopamine signals in the striatum Nat Neurosci 7 2004 583 584 (Pubitemid 38691894)
248. C. Riegert, F. Wedekind, S.B. Hamdia, S. Rutz, A.K. Rothmaier, B.C. Jones, J.C. Cassel, and R. Jackisch Effects of ethanol and 3,4- methylenedioxymethamphetamine (MDMA) alone or in combination on spontaneous and evoked overflow of dopamine, serotonin and acetylcholine in striatal slices of the rat brain Int J Neuropsychopharmacolo. 11 2008 743 763
249. S.C. Riley, C. James, D. Gregory, H. Dingle, and M. Cadger Patterns of recreational drug use at dance events in Edinburgh, Scotland Addiction 96 2001 1035 1047 (Pubitemid 32664603)
250. M.C. Ritz, and M.J. Kuhar Relationship between self-administration of amphetamine and monoamine receptors in brain: comparison with cocaine J Pharmacol Exp Ther 248 1989 1010 1017 (Pubitemid 19100749)
251. M. Rizzo, C.T.J. Lamers, N. Skaar, C.W. Sauer, J. Ramaekers, and G.J. Andersen Perception of heading in abstinent MDMA and THC users J Vis 3 2003 410a (Pubitemid 39111390)
252. M. Rizzo, C.T. Lamers, C.G. Sauer, J.G. Ramaekers, A. Bechara, and G.J. Andersen Impaired perception of self-motion (heading) in abstinent ecstasy and marijuana users Psychpharmacology (Berl). 179 2005 559 566 (Pubitemid 40684426)
253. P. Robledo, C. Balerio, F. Berrendero, and R. Maldonado Study of the behavioral responses related to the potential addictive proprieties of MDMA in mice Naunyn Schmiedebergs Arch Pharmacol 369 2004 338 349 (Pubitemid 38372940)
254. P. Robledo, J.M. Trigo, F. Panayi, R. de la Torre, and R. Maldonado Behavioural and neurochemical effects of combined MDMA and THC administration in mice Psychopharmacology 195 2007 255 264 (Pubitemid 350045837)
255. J. Rodgers Cognitive performance amongst recreational users of "ecstasy" Psychopharmacology 151 2000 19 24 (Pubitemid 30639835)
256. D.F. Rodriguez, T. Wenger, M. Navarro, and L.L. Murphy Effects of D9-THC on VIP-induced prolactin secretion in anterior pituitary cultures: evidence for the presence of functional cannabinoid CB1 receptors in pituitary cells Brain Res 841 1999 114 122 (Pubitemid 29441006)
257. P. Rosa-Neto, A.K. Olsen, A. Gjedde, H. Watanabe, and P. Cumming MDMA-evoked changes in cerebral blood flow in living porcine brain: correlation with hyperthermia Synapse 53 2004 214 221 (Pubitemid 39045540)
258. R.B. Rothman, M.H. Baumann, C.M. Dersch, D.V. Romero, K.C. Rice, F.I. Carroll, and J.S. Partilla Amphetamine-type central nervous system stimulants release norepinephrine more potently than they release dopamine and serotonin Synapse 39 2001 32 41
259. J. Ruiz-Medina, C. Ledent, O. Carreton, and O. Valverde The A2a adenosine receptor modulates the reinforcement efficacy and neurotoxicity of MDMA J Psychopharmacol 25 2011 550 564
260. D.E. Rusyniak, Y. Ootsuka, and W.W. Blessing When administered to rats in a cold environment, 3,4-methylenedioxymethamphetamine reduces brown adipose tissue thermogenesis and increases tail blood flow: effects of pretreatment with 5-HT1A and dopamine D2 antagonists Neuroscience 154 2008 1619 1626
261. K.S. Saadat, J.M. Elliott, M.I. Colado, and A.R. Green Hyperthermic and neurotoxic effect of 3,4-methylenedioxymethamphetamine (MDMA) in guinea pigs Psychopharmacology (Berl). 173 2004 452 453 (Pubitemid 38703822)
262. M. Sala, and D. Braida Endocannabinoids and 3,4- methylenedioxymethamphetamine (MDMA) interaction Pharmacol Biochem Behav 81 2005 407 416 (Pubitemid 40807137)
263. J. Salzmann, C. Marie-Claire, S. Le Guen, B.P. Roques, and F. Noble Importance of ERK activation in behavioral and biochemical effects induced by MDMA in mice Br J Pharmacol 140 2003 831 838 (Pubitemid 37464064)
264. V. Sanchez, J. Camarero, B. Esteban, M.J. Peter, A.R. Green, and M.I. Colado The mechanisms involved in the long lasting neuroprotective effect of fluoxetine against MDMA induced degeneration of 5-HT nerve endings in rat brain Br J Pharmacol 134 2001 46 57 (Pubitemid 32835467)
265. P. Sauseng, W. Klimesch, K.F. Heise, W.R. Gruber, E. Holz, A.A. Karim, M. Glennon, C. Gerloff, N. Birbaumer, and F.C. Hummel Brain oscillatory substrates of visual short-term memory capacity Curr Biol 19 2009 1846 1852
266. M.D. Schechter Candyflipping: synergistic discriminative effect of LSD and MDMA Eur J Pharmacol 1998 341 1998 131 134 (Pubitemid 28131105)
267. S. Schenk MDMA self-administration in laboratory animals: a summary of the literature and proposal for future research Neuropsychobiology 60 2009 130 136
268. S. Schenk, L. Hely, B. Lake, E. Daniela, D. Gittings, and D.C. Mash MDMA self-administration in rats: acquisition, progressive ratio responding and serotonin transporter binding Eur J Neurosci 26 2007 3229 3236 (Pubitemid 350135177)
269. S. Schenk, D. Gittings, and J. Colussi-Mas Dopaminergic mechanisms of reinstatement of MDMA-seeking behavior in rats Br J Pharmacol 162 2011 1770 1780
270. F. Schifano A bitter pill. Overview of ecstasy (MDMA, MDA) related fatalities Psychopharmacology (Berl). 173 2004 242 248 (Pubitemid 38703797)
271. F. Schifano, J. Corkery, P. Deluca, A. Oyefeso, and A.H. Ghodse Ecstasy (MDMA, MDA, MDEA, MBDB) consumption, seizures, related offences, prices, dosage levels and deaths in the UK (1994-2003) J Psychopharmacol 20 2006 456 463
272. C.J. Schmidt Neurotoxicity of the psychedelic amphetamine, methylenedioxymethamphetamine J Pharmac Exp Ther. 240 1987 240 247
273. A.B. Scholey, A.C. Parrott, T. Buchanan, T.M. Heffernan, J. Ling, and J. Rodgers Increased intensity of Ecstasy and polydrug usage in the more experienced recreational Ecstasy/MDMA users: a WWW study Addict Behav 29 2004 743 752 (Pubitemid 38591581)
274. P. Schuster, R. Lieb, C. Lamertz, and H.U. Wittchen Is the use of ecstasy and hallucinogens increasing? Results from a community study Eur Addict Res 4 1998 75 82 (Pubitemid 28163797)
275. M.C. Scorza, C. Carrau, R. Silveira, G. Zapata-Torres, B.K. Cassels, and M. Reyes-Parada Monoamine oxidase inhibitory properties of some methoxylated and alkylthio amphetamine derivatives: structure-activity relationships Biochem Pharmacol 54 1997 1361 1369 (Pubitemid 27521047)
276. H. Sekine, and Y. Nakahara Abuse of smoking methamphetamine mixed with tobacco: I. Inhalation efficiency and pyrolysis products of methamphetamine J Forensic Sci 32 1987 1271 1280 (Pubitemid 17143314)
277. H. Sekine, and Y. Nakahara Abuse of smoking methamphetamine mixed with tobacco: II. The formation mechanism of pyrolysis products J Forensic Sci 35 1990 580 590 (Pubitemid 20151963)
278. D.M. Semple, K.P. Ebmeier, M.F. Glabus, R.E. O'Carroll, and E.C. Johnstone Reduced in vivo binding to the serotonin transporter in the cerebral cortex of MDMA ('ecstasy') users Br J Psychiatry 175 1999 63 69 (Pubitemid 29307857)
279. A.M. Sgaravatti, M.B. Sgarbi, C.G. Testa, K. Durigon, C.D. Pederzolli, C.C. Prestes, A.T. Wyse, C.M. Wannmacher, M. Wajner, and C.S. Dutra-Filho Gamma-hydroxybutyric acid induces oxidative stress in cerebral cortex of young rats Neurochem Int 50 2007 564 570 (Pubitemid 46186607)
280. A.M. Sgaravatti, A.S. Magnusson, A.S. Oliveira, C.P. Mescka, F. Zanin, M.B. Sgarbi, C.D. Pederzolli, A.T. Wyse, C.M. Wannmacher, M. Wajner, and C.S. Dutra-Filho Effects of 1, 4-butanediol administration on oxidative stress in rat brain: study of the neurotoxicity of gamma-hydroxybutyric acid in vivo Metab Brain Dis 24 2009 271 282
281. M. Shankaran, B.K. Yamamoto, and G.A. Gudelsky Involvement of the serotonin transporter in the formation of hydroxyl radicals induced by 3,4-methylenedioxymethamphetamine Eur J Pharmacol 385 1999 103 110
282. J.G. Shin, K. Kane, and D.A. Flockhart Potent inhibition of CYP2D6 by haloperidol metabolites: stereoselective inhibition by reduced haloperidol Br J Clin Pharmacol 51 2001 45 52 (Pubitemid 32118819)
283. R. Simantov, and W. Peng MDMA (Ecstasy) controls in concert a group of genes involved in GABA neurotransmission FEBS Lett 563 2004 3 6 (Pubitemid 38471564)
284. R. Simantov, and M. Tauber The abused drug MDMA (Ecstasy) induces programmed death of human serotonergic cells FASEB J 11 1997 141 146 (Pubitemid 27097587)
285. A.N. Singh, and J. Catalan Rave drug (ecstasy) and selective serotonin reuptake inhibitor anti-depressants Indian Journal of Psychiatry. 42 2000 195 197
286. W.J. Skelton, M.T. Williams, and C.V. Vorhees Developmental effects of MDMA: a review Behav Pharmacol 19 2008 91 111
287. R.G. Smart, and A.C. Ogborne Drug use and drinking among students in 36 countries Addict Behav 25 2000 455 460 (Pubitemid 30235141)
288. J.E. Sprague, and D.E. Nichols Neurotoxicity of MDMA (ecstasy): beyond metabolism Trends Pharmacol Sci 26 2005 59 60
289. N. Stanley, A. Salem, and R.J. Irvine The effects of co-administration of MDMA or PMA and moclobemide at elevated ambient temperatures on striatal 5-HT, body temperature and behavior in rats Neuroscience 146 2007 321 329 (Pubitemid 46654614)
290. H. Sternbach The serotonin syndrome Am J Psychiatry 148 1991 705 713
291. H.R. Sumnall, K. Woolfall, S. Edwards, J.C. Cole, and C.M. Beynon Use, function, and subjective experiences of gamma-hydroxybutyrate (GHB) Drug Alcohol Depend 92 2008 286 290 (Pubitemid 350218199)
292. K. von Sydow, R. Lieb, H. Pfister, M. Ḧofler, H. Sonntag, and H.U. Wittchen The natural course of cannabis use, abuse and dependence over 4 years: a longitudinal community study of adolescents and young adults Drug Alcohol Depend 64 2001 347 361 (Pubitemid 32973878)
293. M.A. Taffe, C.C. Lay, S.N. Von Huben, S.A. Davis, R.D. Crean, and S.N. Katner Hyperthermia induced by 3,4-methylenedioxymethamphetamine in unrestrained rhesus monkeys Drug Alcohol Depend 82 2006 276 281
294. M. Tancer, and C.E. Johanson Reinforcing, subjective and physiological effects of MDMA in humans: a comparison with d-amphetamine and mCPP Drug Alcohol Sepend. 72 2003 33 44 (Pubitemid 37255328)
295. M. Tancer, and C.E. Johanson The effects of fluoxetine on the subjective and physiological effects of MDMA in humans Psychopharmacology (Berl). 189 2007 565 573 (Pubitemid 44791225)
296. E.E. Tanner-Smith Pharmacological content of tablets sold as "ecstasy": results from an online testing service Drug Alcohol Depend 83 2006 247 254
297. T.F.M. Ter Bogt, and R.C.M.E. Engels "Partying" hard: party style, motives for and effects of MDMA use at rave parties Subst Use Misuse 40 2005 1479 1502
298. M.R. Thompson, P.D. Callaghan, G.E. Hunt, J.L. Cornish, and I.S. McGregor A role for oxytocin and 5-HT(1A) receptors in the prosocial effects of 3, 4 methylenedioxymethamphetamine ("ecstasy") Neuroscience 146 2007 509 514 (Pubitemid 46617075)
299. M.R. Thompson, G.E. Hunt, and I.S. McGregor Neural correlates of MDMA ("Ecstasy")-induced social interaction in rats Soc Neurosci 4 2009 60 72
300. L. Topp, J. Hando, P. Dillon, A. Roche, and N. Solowij Ecstasy use in Australia: patterns of use and associated harm Drug Alcohol Depend 55 1999 105 115 (Pubitemid 29222009)
301. C. Tourino, R. Maldonado, and O. Valverde MDMA attenuates THC withdrawal syndrome in mice Psychopharmacology (Berlin). 193 2007 75 84 (Pubitemid 46906631)
302. C. Tourino, C. Ledent, R. Maldonado, and O. Valverde CB1 cannabinoid receptor modulates 3,4-methylenedioxymethamphetamine acute responses and reinforcement Biol Psychiatry 63 2008 1030 1038 (Pubitemid 351636293)
303. C. Touriño, A. Zimmer, and O. Valverde THC prevents MDMA neurotoxicity in mice PLoS One 5 2010 e9143
304. J.M. Trigo, F. Panayi, G. Soria, R. Maldonado, and P. Robledo A reliable model of intravenous MDMA self-administration in naive mice Psychopharmacology (Berl). 184 2006 212 220 (Pubitemid 43083658)
305. J.M. Trigo, M.J. Orejarena, R. Maldonado, and P. Robledo MDMA reinstates cocaine-seeking behaviour in mice Eur Neuropsychopharmacol 19 2009 391 397
306. H. Tsukada, K. Miyasato, T. Kakiuchi, S. Nishiyama, N. Harada, and E.F. Domino Comparative effects of methamphetamine and nicotine on the striatal [(11)C] raclopride binding in unanesthetized monkeys Synapse 45 2002 207 212 (Pubitemid 34827553)
307. G.T. Tucker, M.S. Lennard, S.W. Ellis, H.F. Woods, A.K. Cho, L.Y. Lin, A. Hiratsuka, D.A. Schmitz, and T.Y. Chu The demethylenation of ecstasy by debrisoquine hydroxylase (CYP2D6) Biochem Pharmacol 47 1994 1151 1156
308. United Nations Office on Drugs andCrime (UNODC) World Drug Report, 2010 United Nations Publication Sales No.E.10.XI.13. United Nations, New York, NY, Vienna, Austria: 2010 2010
309. V.V. Upreti, and N.D. Eddington Fluoxetine pretreatment effects pharmacokinetics of MDMA in rats J Pharm Sci 97 2008 1593 1605
310. J.D. Uys, and R.J. Niesink Pharmacological aspects of combined use of MDMA and GHB: a review of the literature Drug Alcohol Rev 24 2005 359 368
311. P.S. van Nieuwenhuijzen, and I.S. McGregor Sedative and hypothermic effects of GHB in rats alone and in combination with other drugs: assessment using biotelemetry Drug Alcohol Depend 103 2009 137 147
312. P.S. van Nieuwenhuijzen, K. Li, G.E. Hunt, and I.S. McGregor Weekly gamma-hydroxybutyrate (GHB) exposure sensitizes locomotor hyperactivity to low dose 3, 4-methylenedioxymethamphetamine (MDMA) in rats Neuropsychobiology 60 2009 195 203
313. P.S. van Nieuwenhuijzen, I.S. McGregor, and G.E. Hunt The distribution of gamma-hydroxybutyrate-induced Fos expression in rat brain: comparison with baclofen Neuroscience 158 2009 441 455
314. P.S. van Nieuwenhuijzen, L.E. Long, G.E. Hunt, J.C. Arnold, and I.S. McGregor Residual social, memory and oxytocin-related changes in rats following repeated exposure to GHB, MDMA or their combination Psychopharmacology (Berl). 212 2010 663 674
315. P.S. van Nieuwenhuijzen, M.A. Kashem, I. Matsumoto, G.E. Hunt, and I.S. McGregor A long hangover from party drugs: residual proteomic changes in the hippocampus of rats 8 weeks after gammahydroxybutyrate (GHB), 3, 4-methylenedioxymethamphetamine (MDMA) or their combination Neurochem Int 56 2010 871 877
316. N. Vanattou-Saïfoudine, R. McNamara, and A. Harkin Mechanisms mediating the ability of caffeine to influence MDMA (Ecstasy)-induced hyperthermia in rats Br J Pharmacol 160 2010 860 877
317. N. Vanattou-Saïfoudine, R. McNamara, and A. Harkin Caffeine promotes dopamine D1 receptor-mediated body temperature, heart rate and behavioral responses to MDMA ('ecstasy') Psychopharmacology (Berl). 211 2010 15 25
318. N. Vanattou-Saïfoudine, A. Gossen, A. Harkin Neuropsychopharmacology Research Group A role for adenosine A1 receptor blockade in the ability of caffeine to promote MDMA "Ecstasy"-induced striatal dopamine release Eur J Pharmacol 650 2011 220 228
319. R.J. Verkes, H.J. Gijsman, M.S. Pieters, R.C. Schoemaker, S. de Visser, M. Kuijpers, E.J. Pennings, D. de Bruin, G. Van de Wijngaart, J.M. Van Gerven, and A.F. Cohen Cognitive performance and serotonergic function in users of ecstasy Psychopharmacology 153 2001 196 202 (Pubitemid 32127887)
320. C.D. Verrico, G.M. Miller, and B.K. Madras MDMA and human dopamine, norepinephrine and serotonin transporters: implications for MDMA-induced neurotoxicity and treatment Psychopharmacology (Berl). 189 2007 489 503 (Pubitemid 44791219)
321. F.X. Vollenweider, A. Gamma, M.E. Liechti, and T. Huber Psychological and cardiovascular effects and short-term sequelae of MDMA ('Ecstasy') in MDMA-naïve healthy volunteers Neuropsychopharmacology 19 1998 241 251 (Pubitemid 28491334)
322. S.N. Von Huben, C.C. Lay, R.D. Crean, S.A. Davis, S.N. Katner, and M.A. Taffe Impact of ambient temperature on hyperthermia induced by 3,4-methylenedioxymethamphetamine in rhesus macaques Neuropsychopharmacology 32 2007 673 681
323. S. Voorspoels, V. Coucke, A. Covaci, J. Maervoet, P. Schepens, C. DeMeyere, and W. Jacobs Resurgence of a lethal drug: paramethoxyamphetamine deaths in Belgium J Toxicol Clin Toxicol 40 2002 203 204 (Pubitemid 34755591)
324. F.A. Wagner, and J.C. Anthony In to the world of illegal drug use: exposure opportunity and other mechanisms linking the use of alcohol, tobacco, marijuana, and cocaine Am J Epidemiol 155 2002 918 925 (Pubitemid 34517848)
325. Z. Wang, and W.L. Woolverton Estimating the relative reinforcing strength of MDMA and its isomers in rhesus monkeys: comparison to [+]-methamphetamine Psychopharmacology (Berl). 189 2007 483 488 (Pubitemid 44791218)
326. X. Wang, M.H. Baumann, H. Xu, and R.B. Rothman 3,4- Methylenedioxymethamphetamine (MDMA) administration to rats decreases brain tissue serotonin but not serotonin transporter protein and glial fibrillary acidic protein Synapse 53 2004 240 248 (Pubitemid 39045543)
327. P.F. White, W.L. Wag, and A.J. Trevor Ketamine: its pharmacology and therapeutic uses Anaesthesiology. 56 1982 119 136 (Pubitemid 12164876)
328. H.C. Wilcox, F.A. Wagner, and J.C. Anthony Exposure opportunity as a mechanism linking youth marijuana use to hallucinogen use Drug Alcohol Depend 66 2002 127 135 (Pubitemid 34245432)
329. M.T. Williams, C.A. Brown, M.R. Skelton, A.A. Vinks, and C.V. Vorhees Absorption and clearance of ± 3, 4-methylenedioxymethamphetamine from the plasma of neonatal rats Neurotoxicol Teratol 26 2004 849 856 (Pubitemid 39296768)
330. A.R. Winstock, P. Griffiths, and D. Stewart Drugs and the dance music scene: a survey of current drug use patterns among a sample of dance music enthusiasts in the UK Drug Alcohol Depend 64 2001 9 17 (Pubitemid 32695429)
331. E.D. Wish, D.B. Fitzelle, K.E. O'Grady, M.H. Hsu, and A.M. Arria Evidence for significant polydrug use among ecstasy-using college students J Am Coll Health 55 2006 99 104 (Pubitemid 44484431)
332. K. Wolff, E.M. Tsapakis, A.R. Winstock, D. Hartley, D. Holt, M.L. Forsling, and K.J. Aitchison Vasopressin and oxytocin secretion in response to the consumption of ecstasy in a clubbing population J Psychopharmacol 20 2006 400 410
333. D. Wu, S.V. Otton, T. Inaba, W. Kalow, and E.M. Sellers Interactions of amphetamine analogs with human liver CYP2D6 Biochem Pharmacol 53 1997 1605 1612 (Pubitemid 27356089)
334. L.T. Wu, W.E. Schlenger, and D.M. Galvin Concurrent use of methamphetamine, MDMA, LSD, Ketamine, GBH, and flunitrazepam among American youths Drug Alcohol Depend 84 2006 102 113 (Pubitemid 44137307)
335. T. Xie, L. Tong, U.D. McCann, J. Yuan, K.G. Becker, A.O. Mechan, C. Cheadle, D.M. Donovan, and G.A. Ricaurte Identification and characterization of metallothionine-1 and 2-gene expression in the context of MDMA induced toxicity to brain dopaminergic neurons J Neurosci 24 2004 7043 7050 (Pubitemid 39096370)
336. J.M. Young, I.S. McGregor, and P.E. Mallet Co-administration of THC and MDMA ('ecstasy') synergistically disrupts memory in rats Neuropsychopharmacology 30 2005 147 182
337. H. Zhang, and D. Sulzer Frequency-dependent modulation of dopamine release by nicotine Nat Neurosci 2004 581 582 (Pubitemid 38691893)